CARDIOPET

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C18H33FO2
Molecular Weight	299.4544
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

CCCCCCCCC([18F])CCCC[C@@H]1C[C@H]1CC(O)=O

InChI

InChIKey=DDTRZLZETKPBPQ-YWWFHXEUSA-N

InChI=1S/C18H33FO2/c1-2-3-4-5-6-7-11-17(19)12-9-8-10-15-13-16(15)14-18(20)21/h15-17H,2-14H2,1H3,(H,20,21)/t15-,16+,17?/m1/s1/i19-1

HIDE SMILES / InChI

Molecular Formula	C18H33FO2
Molecular Weight	299.4544
Charge	0
Count	MOL RATIO 1 MOL RATIO (average)

Stereochemistry	EPIMERIC
Additional Stereochemistry	No
Defined Stereocenters	2 / 3
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical
Record UNII	FDG79C95XB
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

CARDIOPET

Common Name

English

2-((1S,2R)-2-(5-(FLUORO-18F)TRIDECYL)CYCLOPROPYL)ACETIC ACID

Systematic Name

English

TRANS-9(RS)-18F-FLUORO-3,4(RS,RS)-METHYLENEHEPTADECANOIC ACID

Common Name

English

(18F FCPHA)

Common Name

English

CYCLOPROPANEACETIC ACID, 2-(5-(FLUORO-18F)TRIDECYL)-, (1R,2S)-REL-

Systematic Name

English

Showing 1 to 5 of 6 entries

Previous1 2Next

Show entries

Code System

Code

Type

Description

FDA UNII

FDG79C95XB

PRIMARY

SMS_ID

300000042511

PRIMARY

CAS

855927-17-2

PRIMARY

MANUFACTURER PRODUCT INFORMATION

CARDIOPET

PRIMARY

CardioPET is: An F-18 labeled, modified fatty acid that provides insight into regions with decreased blood flow or metabolic insufficiency in the myocardium.; CardioPET may be used to: Identify patients that will benefit from PCI or revascularization and guide intervention, Assess myocardial viability, Evaluate CAD in patients that cannot exercise.; Agent: Muscle State Imaging Agent, Type: Fatty Acid (Labeled with Fluorine 18), Condition: Coronary Artery Disease, Status: completed enrollment.;This imaging agent exploits the dietary needs of the heart as it relates to glucose and fatty acids. By introducing a radio-labeled analog to the natural fatty acids utilized as an energy source by the heart we can visualize the anatomic location and state of the muscle within the areas defined by the specific coronary artery blood flow distribution and detect problems in advance of symptoms that would lead to a stress test.

PUBCHEM

24824703

PRIMARY

Showing 1 to 5 of 5 entries

Previous1Next

Show entries

Related Record

Type

Details


					FDG79C95XB

CARDIOPET

ACTIVE MOIETY

Comments:

CardioPET is: An F-18 labeled, modified fatty acid that provides insight into regions with decreased blood flow or metabolic insufficiency in the myocardium.; CardioPET may be used to: Identify patients that will benefit from PCI or revascularization and guide intervention, Assess myocardial viability, Evaluate CAD in patients that cannot exercise

Showing 1 to 1 of 1 entries

Previous1Next